Related Experiment Video

Updated: May 28, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
07:55

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

Amyloid-β protein precursor gene expression in alzheimer's disease and other conditions

Cyril Pottier1, David Wallon, Anne Rovelet Lecrux

  • 1Inserm U614, Faculty of Medicine, Institute for Biomedical Research and Innovation, University of Rouen, 76000, Rouen, France.

Journal of Alzheimer'S Disease : JAD
|November 3, 2011
PubMed

Insights

Alzheimer's disease (AD) risk is not linked to amyloid precursor protein (AβPP) gene expression in most sporadic AD patients. However, increased AβPP mRNA was found in Down syndrome and AβPP duplication cases.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Amyloid precursor protein (AβPP) gene expression is hypothesized to influence Alzheimer's disease (AD) risk.
  • Understanding AβPP expression levels in various neurological conditions is crucial for disease mechanism research.

Purpose of the Study:

  • To investigate AβPP mRNA expression in peripheral blood cells across different patient groups, including sporadic AD, autosomal dominant early-onset AD (ADEOAD), Down syndrome, AβPP duplication, and recent ischemic stroke.
  • To determine if AβPP overexpression plays a pathogenic role in sporadic AD.

Main Methods:

  • Utilized a sensitive multiplex fluorescent reverse transcription-polymerase chain reaction (RT-PCR) assay.
  • Quantified AβPP mRNA levels in peripheral blood cells from healthy controls and patient cohorts.
  • Compared AβPP expression levels statistically among the groups.

Main Results:

  • AβPP mRNA levels were not significantly increased in sporadic AD or ADEOAD patients compared to healthy controls.
  • Down syndrome patients and patients with AβPP duplication showed significantly elevated AβPP mRNA levels.
  • A modest but significant increase in AβPP transcripts was observed in patients with recent ischemic stroke.

Conclusions:

  • AβPP overexpression does not appear to be a primary pathogenic factor in the majority of sporadic AD cases.
  • Elevated AβPP mRNA levels are strongly associated with Down syndrome and AβPP duplication.
  • A subset of sporadic AD patients may exhibit AβPP overexpression, warranting further investigation.

More Related Videos

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...